The presence of different ALT phenotypes in CML cells [46,55,62] is highly suggestive of the use of various recombination mechanisms, as it has been proposed for normal and malignant cells [19,23,76,77]. This evidence concerns the gene GPT and chronic myelogenous leukemia, BCR-ABL1 positive.